- Diabetes Treatment and Management
- Transplantation: Methods and Outcomes
- Pregnancy and Medication Impact
- Renal Transplantation Outcomes and Treatments
- Bone health and treatments
- Adenosine and Purinergic Signaling
- Sarcoidosis and Beryllium Toxicity Research
- Adolescent and Pediatric Healthcare
- Autoimmune and Inflammatory Disorders Research
- Eosinophilic Disorders and Syndromes
UNSW Sydney
2024
Beijing Children’s Hospital
2008
Introduction Heart transplantation is an important treatment for end-stage heart failure. Early post-transplant hyperglycemia (EPTH) and diabetes mellitus (PTDM) are common following associated with increased morbidity mortality.
Abstract Aims Early post‐transplant hyperglycaemia (EPTH) and diabetes mellitus (PTDM) are common following solid organ transplantation may be associated with adverse outcomes. We studied the prevalence of EPTH cumulative 5‐year PTDM in a modern cohort heart transplant recipients who were free from at baseline as well association EPTH, pre‐transplant T2DM transplant‐related Methods Retrospective study followed for 5 years single centre Sydney, Australia. Results A total 141 patients...
Results 42 patients were diagnosed MAS with SOJIA from 159 cases. The duration prior to is 11 months. High fever, hepatosplenomegaly, pancytopenia, liver dysfunction in all Bleeding was 12. 45% has had CNS dysfunction. 24% ARDS. 2 suffered renal damage. lab.tests revealed elevated live enzymes and ferritin, decreased value of ESR, album, CBC fibrinogen all. Bone marrow examination supported the diagnosis definite haemophagocytosis Lymph node biopsy done for one case found out it filled...